Home » Topics » BioWorld Science

BioWorld Science
RSS

Clarity recruits patients with prostate cancer to evaluate PET imaging with [64Cu]SAR-bisPSMA

July 19, 2021

New neonatal murine model of Listeria monocytogenes meningitis developed

July 19, 2021

Scioto opens phase I study of SB-121 in participants with autistic disorder

July 19, 2021

BIX-119 leads to improved clinical benefit through blocking both IL-17 and IL-22

July 19, 2021

ABBV-CLS-7262 studied in phase I for ALS

July 19, 2021

Phase I trial investigates SHJ-002 for myopia in pediatric subjects

July 19, 2021

FDA clears IND for phase I trial of SYSA-1801 in advanced pancreatic cancer

July 19, 2021

UCB discloses new FCER1A mutant inhibitors

July 19, 2021

FDA accepts IND application for phase IIa study of Quilience as treatment of narcolepsy

July 19, 2021

Wigen Biomedicine Technology presents KRAS mutant inhibitors

July 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...